Page | |
F- 2 | |
F- 3 | |
F- 4 | |
F- 5 | |
F- 6 | |
F- 7 |
|
June 30,
|
December 31,
|
|||||||
|
|
2025
|
2024
|
||||||
|
ASSETS
|
||||||||
|
Current assets:
|
||||||||
|
Cash and cash equivalents
|
$
|
|
$
|
|
||||
|
Marketable securities
|
|
|
||||||
|
User funds
|
|
|
||||||
|
Short-term bank deposits
|
|
|
||||||
|
Restricted deposit
|
|
|
||||||
|
Other receivables
|
|
|
||||||
|
Total current assets
|
|
|
||||||
|
Long-term assets:
|
||||||||
|
Marketable securities
|
|
|
||||||
|
Property and equipment, net
|
|
|
||||||
|
Operating lease right-of-use assets
|
|
|
||||||
|
Intangible assets, net
|
|
|
||||||
|
Goodwill
|
|
|
||||||
|
Other non-current assets
|
|
|
||||||
|
Total long-term assets
|
|
|
||||||
|
Total assets
|
$
|
|
$
|
|
||||
|
LIABILITIES AND SHAREHOLDERS’ EQUITY
|
||||||||
|
Current liabilities:
|
||||||||
|
Trade payables
|
$
|
|
$
|
|
||||
|
User accounts
|
|
|
||||||
|
Deferred revenue
|
|
|
||||||
|
Other account payables and accrued expenses
|
|
|
||||||
|
Operating lease liabilities
|
|
|
||||||
|
Convertible notes, net
|
|
|
||||||
|
Total current liabilities
|
|
|
||||||
|
Long-term liabilities:
|
||||||||
|
Operating lease liabilities
|
|
|
||||||
|
Other non-current liabilities
|
|
|
||||||
|
Total long-term liabilities
|
|
|
||||||
|
Total liabilities
|
$
|
|
$
|
|
||||
|
Commitments and contingencies (see note 7)
|
||||||||
|
Shareholders’ equity:
|
||||||||
|
Shares authorized:
Shares issued and outstanding:
December 31, 2024, respectively
|
||||||||
|
Additional paid-in capital
|
|
|
||||||
|
Accumulated deficit
|
(
|
)
|
(
|
)
|
||||
|
Accumulated other comprehensive income
|
|
|
||||||
|
Total shareholders’ equity
|
|
|
||||||
|
Total liabilities and shareholders’ equity
|
$
|
|
$
|
|
||||
|
Six Months Ended
June 30,
|
||||||||
|
|
2025
|
2024
|
||||||
|
Revenue
|
$
|
|
$
|
|
||||
|
Cost of revenue
|
|
|
||||||
|
Gross profit
|
|
|
||||||
|
Operating expenses:
|
||||||||
|
Research and development
|
|
|
||||||
|
Sales and marketing
|
|
|
||||||
|
General and administrative
|
|
|
||||||
|
Total operating expenses
|
|
|
||||||
|
Operating loss
|
(
|
)
|
(
|
)
|
||||
|
Financial income, net
|
|
|
||||||
|
Income before taxes on income
|
|
|
||||||
|
Taxes on income
|
(
|
)
|
(
|
)
|
||||
|
Net income
|
$
|
|
$
|
|
||||
|
Basic net income per share attributable to ordinary shareholders
|
$
|
|
$
|
|
||||
|
Basic weighted average ordinary shares
|
|
|
||||||
|
Diluted net income per share attributable to ordinary shareholders
|
$
|
|
$
|
|
||||
|
Diluted weighted average ordinary shares
|
|
|
||||||
|
|
Six Months Ended
June 30,
|
|||||||
|
|
2025
|
2024
|
||||||
|
Net income
|
$
|
|
$
|
|
||||
|
Marketable securities:
|
||||||||
|
Unrealized gain (loss)
|
|
(
|
)
|
|||||
|
Derivatives:
|
||||||||
|
Unrealized income (loss)
|
|
(
|
)
|
|||||
|
Amounts reclassified from accumulated other comprehensive income (loss)
|
(
|
)
|
|
|||||
|
Other comprehensive income (loss) for six months ended June 30, 2025 and 2024, respectively
|
|
(
|
)
|
|||||
|
Comprehensive income
|
$
|
|
$
|
|
||||
|
|
Number of
ordinary shares and protected ordinary shares |
Share capital
and additional paid-in capital |
Accumulated
deficit |
Accumulated
other comprehensive income (loss) |
Total
shareholders’ equity |
|||||||||||||||
|
Balance as of December 31, 2024
|
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
|
||||||||||
|
Share-based compensation
|
-
|
|
|
|
|
|||||||||||||||
|
Exercise of share options, vested RSUs and ESPP
|
|
|
|
|
|
|||||||||||||||
|
Issuance of shares related to Earn-out
|
|
|
|
|
|
|||||||||||||||
|
Net income
|
-
|
|
|
|
||||||||||||||||
|
Other comprehensive loss, net
|
-
|
-
|
|
|
|
|||||||||||||||
|
Balance as of June 30, 2025
|
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
|
||||||||||
|
|
Number of
ordinary shares and protected ordinary shares |
Share capital
and additional paid-in capital |
Accumulated
deficit |
Accumulated
other comprehensive income (loss) |
Total
shareholders’ equity |
|||||||||||||||
|
Balance as of December 31, 2023
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
|||||||||
|
Share-based compensation
|
-
|
|
|
|
|
|||||||||||||||
|
Exercise of share options, vested RSUs and ESPP
|
|
|
|
|
|
|||||||||||||||
|
Repurchases of ordinary share
|
(
|
)
|
|
(
|
)
|
|
(
|
)
|
||||||||||||
|
Net income
|
-
|
-
|
|
|
|
|||||||||||||||
|
Other comprehensive loss, net
|
-
|
-
|
|
(
|
)
|
(
|
)
|
|||||||||||||
|
Balance as of June 30, 2024
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
|||||||||
|
|
Six Months Ended
|
|||||||
|
|
June 30,
|
|||||||
|
|
2025
|
2024
|
||||||
|
Cash flows from operating activities:
|
||||||||
|
Net Income
|
$
|
|
$
|
|
||||
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
||||||||
|
Depreciation and amortization
|
|
|
||||||
|
Amortization of premium and accretion of discount on marketable securities, net
|
(
|
)
|
(
|
)
|
||||
|
Amortization of discount and issuance costs of convertible notes
|
|
|
||||||
|
Share-based compensation
|
|
|
||||||
|
Exchange rate fluctuations and other items, net
|
(
|
)
|
|
|||||
|
Revaluation of earn-out
|
|
|
||||||
|
Changes in assets and liabilities:
|
||||||||
|
User funds
|
(
|
)
|
(
|
)
|
||||
|
Operating lease ROU assets and liabilities
|
|
(
|
)
|
|||||
|
Other receivables
|
(
|
)
|
(
|
)
|
||||
|
Trade payables
|
|
(
|
)
|
|||||
|
Deferred revenue
|
|
|
||||||
|
User accounts
|
|
|
||||||
|
Other accounts payable and accrued expenses
|
|
|
||||||
|
Non-current liabilities
|
(
|
)
|
|
|||||
|
Net cash provided by operating activities
|
|
|
||||||
|
Investing activities:
|
||||||||
|
Investment in marketable securities
|
(
|
)
|
(
|
)
|
||||
|
Proceeds from maturities of marketable securities
|
|
|
||||||
|
Investment in short-term bank deposits
|
(
|
)
|
(
|
)
|
||||
|
Proceeds from short-term bank deposits
|
|
|
||||||
|
Acquisition of business, net of cash acquired
|
|
(
|
)
|
|||||
|
Purchase of property and equipment
|
(
|
)
|
(
|
)
|
||||
|
Capitalization of internal-use software
|
(
|
)
|
(
|
)
|
||||
|
Net cash provided by investing activities
|
|
|
||||||
|
Financing activities:
|
||||||||
|
Repurchases of ordinary shares
|
|
(
|
)
|
|||||
|
Proceeds from exercise of share options
|
|
|
||||||
|
Proceeds from withholding tax related to employees’ exercises of share options and RSUs
|
|
|
||||||
|
Net cash provided by (used in) financing activities
|
|
(
|
)
|
|||||
|
Effect of exchange rate fluctuations on cash and cash equivalents
|
|
(
|
)
|
|||||
|
Increase (decrease) in cash and cash equivalents
|
|
|
||||||
|
Cash and cash equivalents at the beginning of the period
|
|
|
||||||
|
Cash and cash equivalents at the end of the period
|
$
|
|
$
|
|
||||
| a. |
Basis of presentation:
|
| b. |
Use of estimates:
|
| c. |
Significant Accounting Policies:
|
| d. |
Concentrations of credit risks:
|
Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, investment in marketable securities, bank deposits, restricted deposit and derivatives, which are placed in major banks in Israel, Germany and the U.S.
| a. |
Praetolia Limited acquisition:
|
|
|
Fair value
|
Amortization
period
|
|||
|
Cash and cash equivalents
|
$
|
|
|
||
|
Assets acquired (1)
|
|
|
|||
|
Identified intangible assets (2):
|
|||||
|
Talent Relationships
|
|
|
|||
|
Customer Relationships
|
|
|
|||
|
Other Customer Relationships
|
|
|
|||
|
Goodwill
|
|
|
|||
|
Total assets acquired
|
|
|
|||
|
Total assumed liabilities (3)
|
(
|
)
|
|
||
|
Net assets acquired
|
$
|
|
|
||
| (1) |
Assets acquired include trade receivables and other receivables.
|
| (2) |
Information regarding the identifiable intangible assets acquired is as follows:
|
| (3) |
Total assumed liabilities includes accounts payable, deferred income tax liabilities, net and other liabilities assumed.
|
| b. |
AutoDS Ltd. acquisition:
|
|
Cash paid
|
$
|
|
||
|
Fair value of Earn-out
|
|
|||
|
Accrued payment
|
|
|||
|
Fair value of unvested options
|
|
|||
|
Total fair value of consideration transferred
|
$
|
|
|
|
Fair value
|
Amortization
period
|
||||||
|
Cash and cash equivalents
|
|
|||||||
|
Assets acquired (4)
|
|
|||||||
|
Identified intangible assets (5):
|
||||||||
|
Users’ Relationships
|
|
|
||||||
|
Technology
|
|
|
||||||
|
Trademark
|
|
|
||||||
|
Goodwill
|
|
|||||||
|
Total assets acquired
|
|
|||||||
|
Total assumed liabilities (6)
|
(
|
)
|
||||||
|
Net assets acquired
|
$
|
|
||||||
| (4) |
Assets acquired include deposits, trade receivable and other identifiable assets acquired.
|
| (5) |
Information regarding the identifiable intangible assets acquired is as follows:
|
| (6) |
Total assumed liabilities includes accounts payable, deferred revenue, deferred income tax liabilities, net and other liabilities assumed.
|
|
|
|
June 30, 2025
|
|||||||||||
|
|
Level 1
|
Level 2
|
Level 3
|
|||||||||
|
Cash and cash equivalents:
|
||||||||||||
|
Cash
|
$
|
|
$
|
|
$
|
|
||||||
|
Money market funds
|
|
|
|
|||||||||
|
Deposits
|
|
|
|
|||||||||
|
Short-term Bank deposits
|
|
|
|
|||||||||
|
Restricted deposits
|
|
|
|
|||||||||
|
Marketable securities
|
|
|
|
|||||||||
|
Asset derivatives (included in other receivables)
|
|
|
|
|||||||||
|
Earn-out
|
|
|
(
|
)
|
||||||||
|
Total
|
$
|
|
$
|
|
$
|
(
|
)
|
|||||
|
|
Fair value
|
|||
|
Fair value as of December 31, 2024
|
$
|
(
|
)
|
|
|
Payment
|
|
|||
|
Change in fair value
|
(
|
) |
||
|
Fair value as of June 30, 2025
|
$
|
(
|
)
|
|
|
|
December 31, 2024
|
|||||||||||
|
|
Level 1
|
Level 2
|
Level 3
|
|||||||||
|
Cash and cash equivalents:
|
||||||||||||
|
Cash
|
$
|
|
$
|
|
$
|
|
||||||
|
Money market funds
|
|
|
|
|||||||||
|
Deposits
|
|
|
|
|||||||||
|
Short-term Bank deposits
|
|
|
|
|||||||||
|
Restricted deposits
|
|
|
|
|||||||||
|
Marketable securities
|
|
|
|
|||||||||
|
Asset derivatives (included in other receivables)
|
|
|
||||||||||
|
Earn-out
|
|
(
|
)
|
|||||||||
|
Total
|
$
|
|
$
|
|
$
|
(
|
)
|
|||||
|
|
Fair value
|
|||
|
Fair value as of June 30, 2024
|
$
|
|
||
|
Acquisition of AutoDS (Note 3)
|
(
|
)
|
||
|
Payment
|
|
|||
|
Change in fair value
|
(
|
)
|
||
|
Fair value as of December 31, 2024
|
$
|
(
|
)
|
|
|
|
Amortized
|
Unrealized
|
Unrealized
|
|||||||||||||
|
|
Cost
|
gains
|
losses
|
Fair Value
|
||||||||||||
|
U.S. Treasury and other U.S. government agencies
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||||
|
Corporate bonds
|
|
|
(
|
)
|
|
|||||||||||
|
Total
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||||
|
|
Amortized
|
Unrealized
|
Unrealized
|
|||||||||||||
|
|
Cost
|
gains
|
losses
|
Fair Value
|
||||||||||||
|
U.S. Treasury and other U.S. government agencies
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||||
|
Corporate bonds
|
|
|
(
|
)
|
|
|||||||||||
|
Total
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||||
|
|
Amortized
|
Unrealized
|
Unrealized
|
|||||||||||||
|
|
Cost
|
gains
|
losses
|
Fair Value
|
||||||||||||
|
Due within one year
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||||
|
Due after one year through two years
|
|
|
|
|
||||||||||||
|
Total
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||||
|
|
Six Months Ended
June 30,
|
|||||||
|
|
2025
|
2024
|
||||||
|
Cost of revenue
|
$
|
(
|
)
|
$
|
|
|||
|
Research and development
|
(
|
)
|
|
|||||
|
Sales and marketing
|
(
|
)
|
|
|||||
|
General and administrative
|
(
|
)
|
|
|||||
|
Total
|
$
|
(
|
)
|
$
|
|
|||
| a. |
Convertible notes
|
|
|
June 30,
|
December 31,
|
||||||
|
2025
|
2024
|
|||||||
|
Principal amounts
|
$
|
|
$
|
|
||||
|
Unamortized issuance costs
|
|
|
||||||
|
Net carrying amount
|
$
|
|
$
|
|
||||
| b. |
Capped call
|
| a. |
Share Repurchase Program:
|
| b. |
Holders of ordinary shares are entitled to one vote per share and dividends whenever funds are legally available and when, as, and if declared by the Company’s board of directors.
|
| c. |
Share options, RSUs and PSUs:
|
|
|
June 30, 2025
|
|||||||||||
|
|
Number of
share options
|
Weighted-
average
exercise
price
|
Weighted-
average
remaining contractual
term
(in years)
|
|||||||||
|
Outstanding as of December 31, 2024
|
|
$
|
|
|
||||||||
|
Granted
|
|
|||||||||||
|
Exercised
|
(
|
)
|
|
|||||||||
|
Forfeited
|
(
|
)
|
|
|||||||||
|
Outstanding as of June 30, 2025
|
|
$
|
|
|
||||||||
|
Exercisable as of June 30, 2025
|
|
$
|
|
|
||||||||
|
|
|
June 30, 2025
|
|
|||||
|
|
|
Number of
RSUs and PSUs
|
|
|
Weighted-
average
grant date
fair value
|
|
||
|
Outstanding as of December 31, 2024
|
|
|
|
$
|
|
|
||
|
Granted
|
|
|
|
|
||||
|
Vested
|
|
|
(
|
|
|
|||
|
Forfeited
|
|
|
(
|
|
|
|||
|
Outstanding as of June 30, 2025
|
|
|
|
$
|
|
|
||
| h. |
Employee Share Purchase Plan:
|
|
|
Six Months Ended June,
|
|||||||
|
|
2025
|
2024
|
||||||
|
Volatility
|
|
|
|
|
||||
|
Expected term in years
|
|
|
||||||
|
Risk-free interest rate
|
|
|
|
|
||||
|
Estimated fair value of underlying ordinary shares
|
|
|
||||||
|
Dividend yield
|
|
|
|
|
||||
|
|
June 30,
|
|||||||
|
|
2025
|
2024
|
||||||
|
Cost of revenue
|
$
|
|
$
|
|
||||
|
Research and development
|
|
|
||||||
|
Sales and marketing
|
|
|
||||||
|
General and administrative
|
|
|
||||||
|
Total
|
$
|
|
$
|
|
||||
|
June 30,
|
||||||||
|
|
2025
|
2024
|
||||||
|
U.S.
|
$
|
|
$
|
|
||||
|
Europe
|
|
|
||||||
|
Asia Pacific
|
|
|
||||||
|
Rest of the world
|
|
|
||||||
|
Israel
|
|
|
||||||
|
Total
|
$
|
|
$
|
|
||||
|
|
June 30,
|
|||||||
|
|
2025
|
2024
|
||||||
|
Marketplace Revenue
|
$
|
|
$
|
|
||||
|
Services Revenue
|
|
|
||||||
|
Total
|
$
|
|
$
|
|
||||